Kim D. Blickenstaff - 27 May 2021 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
Director
Signature
s/ David B. Berger, Attorney-in-Fact for Kim D. Blickenstaff
Issuer symbol
TNDM
Transactions as of
27 May 2021
Net transactions value
$0
Form type
4
Filing time
01 Jun 2021, 19:19:23 UTC
Previous filing
20 May 2021
Next filing
10 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Options Exercise $0 +1,892 $0.000000 1,892 27 May 2021 Direct
holding TNDM Common Stock 452,390 27 May 2021 See Footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Restricted Stock Unit Options Exercise $0 -1,892 -100% $0.000000* 0 27 May 2021 Common Stock 1,892 Direct F2, F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010.
F2 Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).
F3 Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the Company.
F4 This RSU award was granted on May 27, 2020. 100% of the RSU vested on May 27, 2021.
F5 RSU vest as to one-hundred percent (100%) of the total number of shares subject to the RSU on 5/27/2021.